These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 18651641

  • 1. Occupancy of dopamine D2/3 receptors in rat brain by endogenous dopamine measured with the agonist positron emission tomography radioligand [11C]MNPA.
    Seneca N, Zoghbi SS, Skinbjerg M, Liow JS, Hong J, Sibley DR, Pike VW, Halldin C, Innis RB.
    Synapse; 2008 Oct; 62(10):756-63. PubMed ID: 18651641
    [Abstract] [Full Text] [Related]

  • 2. Dopamine D(2/3) receptor occupancy of apomorphine in the nonhuman primate brain--a comparative PET study with [11C]raclopride and [11C]MNPA.
    Finnema SJ, Halldin C, Bang-Andersen B, Gulyás B, Bundgaard C, Wikström HV, Farde L.
    Synapse; 2009 May; 63(5):378-89. PubMed ID: 19173265
    [Abstract] [Full Text] [Related]

  • 3. Effect of risperidone on high-affinity state of dopamine D2 receptors: a PET study with agonist ligand [11C](R)-2-CH3O-N-n-propylnorapomorphine.
    Kodaka F, Ito H, Takano H, Takahashi H, Arakawa R, Miyoshi M, Okumura M, Otsuka T, Nakayama K, Halldin C, Farde L, Suhara T.
    Int J Neuropsychopharmacol; 2011 Feb; 14(1):83-9. PubMed ID: 20860881
    [Abstract] [Full Text] [Related]

  • 4. Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride.
    Seneca N, Finnema SJ, Farde L, Gulyás B, Wikström HV, Halldin C, Innis RB.
    Synapse; 2006 Apr; 59(5):260-9. PubMed ID: 16416444
    [Abstract] [Full Text] [Related]

  • 5. D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.
    Peng T, Zysk J, Dorff P, Elmore CS, Ström P, Malmquist J, Ding M, Tuke D, Werkheiser J, Widzowski D, Mrzljak L, Maier D.
    Synapse; 2010 Aug; 64(8):624-33. PubMed ID: 20340171
    [Abstract] [Full Text] [Related]

  • 6. Quantitative PET analysis of the dopamine D2 receptor agonist radioligand 11C-(R)-2-CH3O-N-n-propylnorapomorphine in the human brain.
    Otsuka T, Ito H, Halldin C, Takahashi H, Takano H, Arakawa R, Okumura M, Kodaka F, Miyoshi M, Sekine M, Seki C, Nakao R, Suzuki K, Finnema S, Hirayasu Y, Suhara T, Farde L.
    J Nucl Med; 2009 May; 50(5):703-10. PubMed ID: 19372485
    [Abstract] [Full Text] [Related]

  • 7. (18)F-MCL-524, an (18)F-Labeled Dopamine D2 and D3 Receptor Agonist Sensitive to Dopamine: A Preliminary PET Study.
    Finnema SJ, Stepanov V, Nakao R, Sromek AW, Zhang T, Neumeyer JL, George SR, Seeman P, Stabin MG, Jonsson C, Farde L, Halldin C.
    J Nucl Med; 2014 Jul; 55(7):1164-70. PubMed ID: 24790219
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological characterization of 2-methoxy-N-propylnorapomorphine's interactions with D2 and D3 dopamine receptors.
    Skinbjerg M, Namkung Y, Halldin C, Innis RB, Sibley DR.
    Synapse; 2009 Jun; 63(6):462-75. PubMed ID: 19217026
    [Abstract] [Full Text] [Related]

  • 9. Differential effects of stress on [¹¹C]raclopride and [¹¹C]MNPA binding to striatal D₂/D₃ dopamine receptors: a PET study in conscious monkeys.
    Tsukada H, Ohba H, Nishiyama S, Kakiuchi T.
    Synapse; 2011 Jan; 65(1):84-9. PubMed ID: 20687105
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and evaluation in rats of the dopamine D2/3 receptor agonist 18F-AMC20 as a potential radioligand for PET.
    Shalgunov V, van Wieringen JP, Janssen HM, Fransen PM, Dierckx RA, Michel MC, Booij J, Elsinga PH.
    J Nucl Med; 2015 Jan; 56(1):133-9. PubMed ID: 25476538
    [Abstract] [Full Text] [Related]

  • 11. Test-retest reproducibility of dopamine D2/3 receptor binding in human brain measured by PET with [11C]MNPA and [11C]raclopride.
    Kodaka F, Ito H, Kimura Y, Fujie S, Takano H, Fujiwara H, Sasaki T, Nakayama K, Halldin C, Farde L, Suhara T.
    Eur J Nucl Med Mol Imaging; 2013 Apr; 40(4):574-9. PubMed ID: 23238524
    [Abstract] [Full Text] [Related]

  • 12. A preliminary PET evaluation of the new dopamine D2 receptor agonist [11C]MNPA in cynomolgus monkey.
    Finnema SJ, Seneca N, Farde L, Shchukin E, Sóvágó J, Gulyás B, Wikström HV, Innis RB, Neumeyer JL, Halldin C.
    Nucl Med Biol; 2005 May; 32(4):353-60. PubMed ID: 15878504
    [Abstract] [Full Text] [Related]

  • 13. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
    Ginovart N, Galineau L, Willeit M, Mizrahi R, Bloomfield PM, Seeman P, Houle S, Kapur S, Wilson AA.
    J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
    [Abstract] [Full Text] [Related]

  • 14. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
    Narendran R, Slifstein M, Guillin O, Hwang Y, Hwang DR, Scher E, Reeder S, Rabiner E, Laruelle M.
    Synapse; 2006 Dec 01; 60(7):485-95. PubMed ID: 16952157
    [Abstract] [Full Text] [Related]

  • 15. Imaging of dopamine D2/3 agonist binding in cocaine dependence: a [11C]NPA positron emission tomography study.
    Narendran R, Martinez D, Mason NS, Lopresti BJ, Himes ML, Chen CM, May MA, Price JC, Mathis CA, Frankle WG.
    Synapse; 2011 Dec 01; 65(12):1344-9. PubMed ID: 21780185
    [Abstract] [Full Text] [Related]

  • 16. Kinetic brain analysis and whole-body imaging in monkey of [11C]MNPA: a dopamine agonist radioligand.
    Seneca N, Skinbjerg M, Zoghbi SS, Liow JS, Gladding RL, Hong J, Kannan P, Tuan E, Sibley DR, Halldin C, Pike VW, Innis RB.
    Synapse; 2008 Sep 01; 62(9):700-9. PubMed ID: 18566975
    [Abstract] [Full Text] [Related]

  • 17. Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein.
    Cumming P, Wong DF, Gillings N, Hilton J, Scheffel U, Gjedde A.
    J Cereb Blood Flow Metab; 2002 May 01; 22(5):596-604. PubMed ID: 11973432
    [Abstract] [Full Text] [Related]

  • 18. Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [11C]-(+)-PHNO.
    Slifstein M, Abi-Dargham A, Girgis RR, Suckow RF, Cooper TB, Divgi CR, Sokoloff P, Leriche L, Carberry P, Oya S, Joseph SK, Guiraud M, Montagne A, Brunner V, Gaudoux F, Tonner F.
    Psychopharmacology (Berl); 2020 Feb 01; 237(2):519-527. PubMed ID: 31773210
    [Abstract] [Full Text] [Related]

  • 19. Estimating endogenous dopamine levels at D2 and D3 receptors in humans using the agonist radiotracer [(11)C]-(+)-PHNO.
    Caravaggio F, Nakajima S, Borlido C, Remington G, Gerretsen P, Wilson A, Houle S, Menon M, Mamo D, Graff-Guerrero A.
    Neuropsychopharmacology; 2014 Nov 01; 39(12):2769-76. PubMed ID: 24874713
    [Abstract] [Full Text] [Related]

  • 20. Radiosynthesis and ex vivo evaluation of (R)-(-)-2-chloro-N-[1-11C-propyl]n-propylnorapomorphine.
    Palner M, McCormick P, Gillings N, Begtrup M, Wilson AA, Knudsen GM.
    Nucl Med Biol; 2010 Jan 01; 37(1):35-40. PubMed ID: 20122666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.